Intellus Advisors »

Precigen shares owned by Intellus Advisors

Quarter-by-quarter ownership of Precigen (PGEN) shares owned by Intellus Advisors from 13F filings

Historical chart of Intellus Advisors investment in Precigen

Tip: Access up to 7 years of quarterly data

All positions including Precigen held by Intellus Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Precigen by Intellus Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $52k 16k 3.29
2025-06-30 $23k 16k 1.42

More positions owned by Intellus Advisors

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Gold Tr Ishares Ishares New (IAU)
Vanguard Dividend Appreciation Etf Div App Etf (VIG)
Jpmorgan U.s. Quality Factor Etf Us Qualty Fctr (JQUA)
American Century Quality Diversified International Etf Quality Divrsfed (QINT)
Hartford Multifactor Developed Markets Hartford Mlt Etf (RODM)
J P Morgan Etf Active Value Etf Active Value Etf (JAVA)
First Trust Value Line Dividend Index Fund SHS (FVD)
Cambria Shareholder Yield Etf Shshld Yield Etf (SYLD)
First Trust Nasdaq Rising Dividend Achievers Risng Divd Achiv (RDVY)
Apple (AAPL)
Wheaton Precious Metals Corp (WPM)
Alphabet Incorporated Cap Stk Class A Cap Stk Cl A (GOOGL)
Franco-Nevada Corporation (FNV)
JPMorgan Chase & Co. (JPM)

View all positions for Intellus Advisors

Top funds holding Precigen

Patient Capital Management
Tang Capital Management
BlackRock
Vanguard Group
Caption Management
State Street Corporation
Geode Capital Management
Iridian Asset Management
Citadel Advisors
Susquehanna International
Point72 Asset Management
Parkman Healthcare Partners
Driehaus Capital Management
Morgan Stanley
Northern Trust

View all funds holding Precigen